These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas. Uhlén N; Grundberg O; Jacobsson H; Sundin A; Dobra K; Sánchez-Crespo A; Axelsson R; Kölbeck KG Clin Nucl Med; 2016 Apr; 41(4):263-7. PubMed ID: 26828139 [TBL] [Abstract][Full Text] [Related]
4. Differential diagnostic value of Zhao J; Wang H Acad Radiol; 2022 Feb; 29 Suppl 2():S41-S46. PubMed ID: 33183953 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids. Jindal T; Kumar A; Venkitaraman B; Meena M; Kumar R; Malhotra A; Dutta R Cancer Imaging; 2011 Jun; 11(1):70-5. PubMed ID: 21697027 [TBL] [Abstract][Full Text] [Related]
6. Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT). Turan O; Ozdogan O; Gurel D; Onen A; Kargi A; Sevinc C Clin Respir J; 2013 Jan; 7(1):e1-5. PubMed ID: 22129499 [TBL] [Abstract][Full Text] [Related]
7. Are the 18F-FDG positron emission tomography/computed tomography findings in bronchopulmonary carcinoid tumors different than expected? Alpay L; Lacin T; Kanbur S; Kiral H; Ersoz E; Bayram S; Dogruyol T; Baysungur V; Yalcinkaya I Hell J Nucl Med; 2013; 16(3):213-7. PubMed ID: 24251310 [TBL] [Abstract][Full Text] [Related]
8. Re: 18F-FDG PET/CT Versus Contrast-Enhanced CT for Staging and Prognostic Prediction in Patients With Salivary Gland Carcinomas. Sabour S Clin Nucl Med; 2017 Dec; 42(12):990. PubMed ID: 28737578 [No Abstract] [Full Text] [Related]
9. Diagnostic performances of 68Ga-DOTATOC versus 18Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumours and interrelationship with histological features. Lococo F; Rapicetta C; Mengoli MC; Filice A; Paci M; Di Stefano T; Coruzzi C; Versari A Interact Cardiovasc Thorac Surg; 2019 Jun; 28(6):957-960. PubMed ID: 30753507 [TBL] [Abstract][Full Text] [Related]
10. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours. Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005 [TBL] [Abstract][Full Text] [Related]
11. Synchronous bilateral bronchial carcinoid diagnosed with combined dual tracer ((18)F-FDG and (68)Ga-DOTATOC) PET/CT scans. Paci M; Lococo F; Rapicetta C; Roncali M; Cavazza A; Treglia G; Sgarbi G Rev Esp Med Nucl Imagen Mol; 2014; 33(4):247-8. PubMed ID: 24140023 [No Abstract] [Full Text] [Related]
12. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
13. Enhanced CT and FDG PET/CT findings of splenic hamartoma. Dong A; Wang Y; Lu J; Zuo C Clin Nucl Med; 2014 Nov; 39(11):968-71. PubMed ID: 24152626 [TBL] [Abstract][Full Text] [Related]
17. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels. Ozkan E; Soydal C; Araz M; Kir KM; Ibis E Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859 [TBL] [Abstract][Full Text] [Related]
18. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules. Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584 [TBL] [Abstract][Full Text] [Related]
19. Giant pulmonary chondroid hamartoma: imaging and pathology correlation of a rare tumor demonstrated with bone scintigraphy and 18F-FDG PET/CT. Lio E; Aisner DL; Askin FB; Kwak JJ Clin Nucl Med; 2015 Jan; 40(1):79-81. PubMed ID: 25275419 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study. Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]